Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
REXO1 like 10, pseudogene (REXO1L10P) is a human pseudogene. By definition, a pseudogene is a genomic DNA sequence similar to a known gene but typically nonfunctional due to disabling mutations such as frameshifts or premature stop codons. REXO1L10P shows sequence homology to the functional RNA exonuclease 1 homolog (REXO1), but does not encode a functional protein product. There is no evidence supporting a functional biological role, protein translation, or involvement in any disease or drug response. Like other pseudogenes, while possible regulatory RNA-level functions (such as acting as a microRNA sponge) are described for some pseudogenes in the literature, there is no specific evidence for such a role for REXO1L10P. REXO1L10P is not considered a druggable or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on REXO1 like 10, pseudogene (REXO1L10P).